HAL vs MNPR · P/E 9.3, $19.05B cap vs $431.4M cap
Halliburton Company (HAL) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported MNPR revenue for 2024-12-31 was $0. Net income was -$15.6M. MNPR currently screens at market cap $431.4M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the HAL and MNPR stock pages for the full models.
Not investment advice.